As of Feb 17
| +0.35 / +0.44%|
The 22 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 87.50, with a high estimate of 103.00 and a low estimate of 70.00. The median estimate represents a +8.84% increase from the last price of 80.39.
The current consensus among 24 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.